Related Experiment Video
Updated: Jan 5, 2026
11:10
Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
16.8K
Type 1 diabetes mellitus and coronary revascularization
Helene Mamet1, Mark C Petrie1,2, Paul Rocchiccioli1
1Department of Cardiology, Golden Jubilee National Hospital.
Cardiovascular Endocrinology & Metabolism
|October 25, 2019
Summary
Coronary revascularization trials often overlook type 1 diabetes, conflating it with type 2. More research is needed to understand type 1 diabetes
Area of Science:
- Cardiology
- Endocrinology
- Clinical Trials
Background:
- Coronary revascularization trials have historically grouped diabetic patients, primarily focusing on type 2 diabetes.
- The specific impact of type 1 diabetes on coronary artery disease and myocardial health remains under-investigated.
Purpose of the Study:
- To review existing evidence on coronary revascularization in patients with type 1 diabetes.
- To highlight the critical knowledge gaps regarding the efficacy and safety of revascularization in this population.
Main Methods:
- Systematic review of literature concerning coronary revascularization trials involving diabetic patients.
- Analysis of studies that differentiate between type 1 and type 2 diabetes, if available.
- Identification of research addressing the effects of type 1 diabetes on coronary vasculature and myocardium.
Main Results:
- Most coronary revascularization trials do not report the number of type 1 diabetes patients, suggesting their exclusion or misclassification.
- Limited data exists on how type 1 diabetes influences coronary endothelial function, arterial walls, and myocardial viability compared to type 2 diabetes.
- The term 'diabetic cardiomyopathy' in type 1 diabetes lacks clear definition and investigation.
Conclusions:
- There is a significant deficit in research evaluating the benefits and risks of coronary revascularization specifically for type 1 diabetes patients.
- Further investigations are crucial to characterize coronary and myocardial disease in type 1 diabetes.
- Dedicated clinical trials are necessary to establish optimal revascularization strategies for individuals with type 1 diabetes, despite potential challenges.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
01:22Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
01:15Diabetes: Management and Pharmacotherapy
828
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
828
01:30Coronary Artery Disease I: Introduction
837
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
837
01:36Carbohydrate Metabolism
13.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.7K
01:27Coronary Artery Disease V: Interprofessional Care
200
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
200